Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.
2 reports, 2 independent
Updated Jul 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Bio-Techne partners with Spear Bio to distribute its immunoassays.1 source
Bio-Techne formed a strategic distribution partnership with Spear Bio and participated in its Series A funding.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- PR NewswireBio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection MINNEAPOLIS, July 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (N
- Business WireSpear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology WOBURN, Mass., July 15, 2025--(BUSINESS WIRE)--Spear Bio, a biotec